A Public Health Paradox: The Women Most Vulnerable to Malaria Are the Least Protected

English version České info

Raquel Gonzalez and colleagues highlight an urgent need to evaluate antimalarials that can be safely administered to HIV-infected pregnant women on antiretroviral treatment and cotrimoxazole prophylaxis.

Vyšlo v časopise: A Public Health Paradox: The Women Most Vulnerable to Malaria Are the Least Protected. PLoS Med 13(5): e32767. doi:10.1371/journal.pmed.1002014
Kategorie: Essay
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002014

Souhrn

Zdroje

1. UNAIDS/WHO. Global report: UNAIDS report on the global AIDS Epidemic 2013. WHO Library Cataloguing-in-Publication Data 2013;UNAIDS(JC2502/1/E).

2. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010;7(1):e1000221. Epub 2010/02/04. doi: 10.1371/journal.pmed.1000221 20126256; PubMed Central PMCID: PMCPMC2811150.

3. WHO. HIV in Pregnancy: a review. WHO UNAIDS. 1998. http://www.unaids.org/sites/default/files/media_asset/jc151-hiv-in-pregnancy_en_1.pdf.

4. Menendez C, Ferenchick E, Roman E, Bardaji A, Mangiaterra V. Malaria in pregnancy: challenges for control and the need for urgent action. The Lancet Global health. 2015;3(8):e433–4. Epub 2015/07/19. doi: 10.1016/s2214-109x(15)00041-8 26187483.

5. Gonzalez R, Ataide R, Naniche D, Menendez C, Mayor A. HIV and malaria interactions: where do we stand? Expert Rev Anti Infect Ther. 2012;10(2):153–65. doi: 10.1586/eri.11.167 22339190.

6. Gonzalez R, Desai M, Macete E, Ouma P, Kakolwa MA, Abdulla S, et al. Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Infected Women Receiving Cotrimoxazole Prophylaxis: A Multicenter Randomized Placebo-Controlled Trial. PLoS Med. 2014;11(9):e1001735. Epub 2014/09/24. doi: 10.1371/journal.pmed.1001735 25247995.

7. WHO. Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP). Updated WHO Policy Recommendation. WHO. 2012;http://www.who.int/malaria/iptp_sp_updated_policy_recommendation_en_102012.pdf.

8. WHO. Consolidated guidelines on the Use of Antiretroviral Drugs for treating and Preventing HIV infection. Recommendations for a public health approach. WHO. 2013;ISBN 978 92 4 150572 7.

9. Sicuri E, Bardaji A, Nhampossa T, Maixenchs M, Nhacolo A, Nhalungo D, et al. Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique. PloS ONE. 2010;5(10):e13407. 20976217. doi: 10.1371/journal.pone.0013407

10. Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, et al. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis. 2012;12(12):942–9. Epub 2012/09/22. doi: 10.1016/s1473-3099(12)70222-0 22995852.

11. Kapito-Tembo A, Meshnick SR, van Hensbroek MB, Phiri K, Fitzgerald M, Mwapasa V. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi. J Infect Dis. 2011;203(4):464–72. 21216867. doi: 10.1093/infdis/jiq072

12. Klement E, Pitche P, Kendjo E, Singo A, D'Almeida S, Akouete F, et al. Effectiveness of Co-trimoxazole to Prevent Plasmodium falciparum Malaria in HIV-Positive Pregnant Women in Sub-Saharan Africa: An Open-Label, Randomized Controlled Trial. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2014. Epub 2013/12/18. doi: 10.1093/cid/cit806 24336820.

13. Manyanga VP, Minzi O, Ngasala B. Prevalence of malaria and anaemia among HIV infected pregnant women receiving co-trimoxazole prophylaxis in Tanzania: a cross sectional study in Kinondoni Municipality. BMC pharmacology & toxicology. 2014;15:24. Epub 2014/04/26. doi: 10.1186/2050-6511-15-24 24761799; PubMed Central PMCID: PMCPMC4014408.

14. Hochman SE, Madaline TF, Wassmer SC, Mbale E, Choi N, Seydel KB, et al. Fatal Pediatric Cerebral Malaria Is Associated with Intravascular Monocytes and Platelets That Are Increased with HIV Coinfection. mBio. 2015;6(5). Epub 2015/09/24. doi: 10.1128/mBio.01390-15 26396242.

15. MiPc. Malaria in Pregnancy consortium Projects. http://wwwmip-consortiumorg/research_projects/.

16. WHO. WHO Policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). World Health Organization Geneva. 2013 (revised 2014);WHO/HTM/GMP/2014.4. http://www.who.int/malaria/publications/atoz/iptp-sp-updated-policy-brief-24jan2014.pdf?ua=1.

17. WHO. Guideline on When to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV. WHO. 2015. http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf?ua=1.

18. Isoherranen N, Thummel KE. Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes? Drug metabolism and disposition: the biological fate of chemicals. 2013;41(2):256–62. Epub 2013/01/19. doi: 10.1124/dmd.112.050245 23328895; PubMed Central PMCID: PMCPMC3558867.

19. Kloprogge F, McGready R, Phyo AP, Rijken MJ, Hanpithakpon W, Than HH, et al. Opposite malaria and pregnancy effect on oral bioavailability of artesunate—a population pharmacokinetic evaluation. Br J Clin Pharmacol. 2015;80(4):642–53. Epub 2015/04/17. doi: 10.1111/bcp.12660 25877779.

20. Rattanapunya S, Cressey TR, Rueangweerayut R, Tawon Y, Kongjam P, Na-Bangchang K. Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults. Malar J. 2015;14(1):400. Epub 2015/10/11. doi: 10.1186/s12936-015-0916-8 26452725; PubMed Central PMCID: PMCPMC4600319.

21. Rattanapunya S, Cressey TR, Ruengweerayut R, Tawon Y, Kongjam P, Na-Bangchang K. Pharmacokinetic Interactions Between Quinine and Lopinavir/Ritonavir in Healthy Thai Adults. Am J Trop Med Hyg. 2015. Epub 2015/09/30. doi: 10.4269/ajtmh.15-0453 26416104.